Macroprolactinaemia;Makroprolaktynemia

Polski Merkuriusz Lekarski

Volumn 29, Issue 169, 2010, Pages 47-49

  Mȩczekalski, Błazej ^a   Kostrzak, Anna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Forms of prolactin; Hyperprolactinaemia; Macroprolactinaemia; Prolactin

Indexed keywords

EID: 77955949716     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Andrews Z.B.: Neuroendocrine regulation of prolactin secretion during late pregnancy: easing the transition into lactation. J. Neuroendocrinol., 2005, 17 (7), 466-473.
2. Berinder K., Stackenas I., Akre O. i wsp.: Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up. Clin. Endocrinol. (Oxf)., 2005, 63 (4),450-455.
3. Biller B.M., Luciano A., Croskjnani P.G. i wsp.: Guidelines for the diagnosis and treatment of hyperprolactinemia. J. Reprod. Med., 1999, 39, 63-64.
4. Bjoro T., Morkrid L, Wergeland R. i wsp.: Frequency of hyperparolctinaemia due to large molecular weight prolactin (150-170 kD PRL). Scand. J. Clin. Lab. Investig., 1995, 55, 139-147.
5. Bracero N., Zacur H.A.: Polycystic ovary syndrome and hyperprolactinaemia. Obstet Gynecol. Clin. North Am., 2001, 28 (1), 77-84.
6. Cattaneo F., Kappeler D., Muller B.: Macroprolactinaemia, the major unknown in the differential diagnosis of hypeprolactinaemia: 10 cases and discussion of diagnostic clues. Swiss. Med. Wkiy., 2001,131, 122-126.
7. David S.R., Taylor CC, Kinon B.J.: The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. Clin. Ther., 2000, 22, 1085-1096.
8. Davis J.R.: Prolactin and reproductive medicine. Curr. Opin. Obstet. Gynecol., 2004, 16 (4), 331-337.
9. De Zegher F., Van Den Berghe G., Devlieger H. i wsp.: Dopamine inhibits growth hormone and prolactin secretion in the human newborn. Pediatr. Res., 1993, 34(5), 642-645.
10. Dzeranova L.K., Goncharov N.P., Dobracheva A.D. i wsp.: The diagnostic value of macroprolactin in hyperprolactinaemia. Klin. Lab. Diagn.,2007, 10, 16-19.
11. Fahie-Wilson M.R., John R., Ellis A.R.: Macroprolactin; high molecular mass forms of circulating prolactin. Ann. Clin. Biochem., 2005, 42,(Pt 3), 175-192.
12. Gordon CM., Nelson L.M.: Amenorrhea and bone health in adolescents and young women. Curr. Opin. Obstet. Gynecol., 2003, 15 (5), 377-384.
13. Hattori N., Inagaki C: Anti-prolactin (PRL) autoantibodies cause asymptomatic hypeprolactinaemia: bioassay and clearance studies of PRL-im-munoglobulin G complex.
14. J. Clin. Endocrinol. Metab., 1997, 82, 3107-3110; J. Clin. Endocrinol. Metab., 2002,87 (10), 4833-4834.
15. Jackson R.D., Wortsman J., Malarkey W.B.: Macroprolactinaemia presenting like a pituitary tumor. Am. J. Med., 1985, 78, 346-350.
16. Jara L.J., Medina G., Saavedra M.A. i wsp.: Prolactin and Autoimmunology. Clin. Rev. Allergy Immunol., 2009, Nov 13.
17. Kavanagh-Wright L., Smith T.P., Gibney J., McKenna T.J.: Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients. Clin. Endocrinol. (Oxf), 2008, Sep 2.
18. Kostrzak A., Warenik-Szymankiewicz A., Meczekalski B: The role of serum PRL bioactivity evaluation in hyperprolactinaemic women with different menstrual disorders. Gynecol. Endocrinol., 2009, 25(12), 799-806.
19. Kozakova D., Drovensky J., Cebecauer L. i wsp.: Prolactin levels and autoantibodies in female patients with systemic lupus Erythematosus. Z. Rheumatol., 2000, 59, 2, II/80-84.
20. Leslie H., Courtney C.H., Bell P.M. i wsp.: Laboratory and clinical experience in 55 patients with macroprolactinaemia identifed by a simple polyethylene glycol precipitation metod. J. Clin. Endocrinol. Metab., 2001, 86 (6), 2743-2746.
21. Lobo R.A., Kletzy O.A., Kaptein E.M., Goebelsman U.: Prolactin modulation of dehydroepiandrosterone sulfate secretion. Am. J. Obstet. Gynecol., 1980, 138, 632-636.
22. Man P.M., Webster J.: Hyperprolactinaemia: etiology, diagnosis, and management. Semin. Reprod. Med., 2002, 20 (4), 365-374.
23. Miyai K., Ichihara K., Kondo K., Mori S.: Asymptomatic hyperprolactinaemia and prolactinoma in the general population-mass screening by paired assays of serum prolactin. Clin. Endocrinol. (Oxf), 1986, Nov, 25 (5), 549-554.
24. Molitch M.E.: Disorders of prolactin secretion. Endocrinol. Metab. Clin.North A, 2008, Sep, 30 (3), 585-610.
25. Riddle O., Bates W.R., Dykshom W.S.: A new hormone of the anteriorpituitary. Proc. Soc. Exptl. Biol. Med., 1932, 29, 1211-1121.
26. Scand. J. Clin. Lab. Invest., 1995, Apr, 55 (2),139-147.
27. Sinkunas K., Rastenyte D., Deltuva V.P. i wsp.: Transsphenoidal surgery for prolactinomas: results and prognosis. Medicina (Kanas), 2007,43 (9), 691-697.
28. Speroff L., Glass R., Kase G.N.: The breast. Clin. Gynecol. Endocrinol. Intertility.1999, Lippincott Williams & Wilkins, 595-641.
29. Speroff L., Fritz M.: Brak miesia̧czki (amenorrhoea). W: Kliniczna endokrynologiczna ginekologia i nieplodność, Medipage, 2007, 459-532.
30. Strieker P., Gruter F.: Action du lobe anterieur de l'hypophyse sur la mon-tee laiteuse. Compt. Soc. Biol., 1928, 99, 1978-1980.
31. Tashjian A.H., Barowsky N.J., Jenses D.K: Thyrotropin releasing hormone: direct evidence for stimulation of prolactin production by pituitary cells in culture. Biochem.Biophys. Res. Communicat.,1971, 43, 516-554.
32. Toldy E., Locsei Z., Szabolcs I. i wsp.: Macroprolactinaemia in the different diagnosis of hyperprolactinaemia. Orv. Hetil., 2003, Oct, 26,144 (43), 2121-2127.
33. Vallette-Kasicc S., Morange-Ramos I., Selim A. i wsp.: Macroprolactinaemia revisited: a study on 106 patients. J. Clin. Endocrinol. Metab., 2002, 87 (10), 4833-4834.
34. Verhelst J., Abs R.: Hyperprolactinaemia: pathophysiology and management. Treat Endocrinol., 2003, 2 (1), 23-32.
35. Whittaker P.G., Wilcom T., Lind T.: Maintained fertility in a patient with hyperprolactinaemia due to big-big prolactin. J. Clin. Endocrinol. Metab. 1981. 53. 863-866.